Over the past two decades, MRI has come to play a prominent role in the diagnosis of Alzheimer Dementia (AD). Findings that have a high sensitivity for AD are medial temporal lobe atrophy (Fig. 1) and parietal atrophy (Fig. 2), especially when both are present in the same patient. If MRI is contraindicated or not available, CT is a good alternative with which global and medial temporal lobe atrophy as well as the extent of white matter lesions may be reliably assessed.
Dementia With Lewy Body Frontotemporal Dementia Alzheimer Dementia Medial Temporal Lobe Atrophy Color Reproduction
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in to check access.
Frisoni GB, Fox NC, Jack CR Jr et al (2010) The clinical use of structural MRI in Alzheimer disease. Nat Rev Neurol 6:67–77PubMedCrossRefGoogle Scholar
Jack CR Jr, Wiste HJ, Vemuri P et al; Alzheimer’s Disease Neuroimaging Initiative (2010) Brain beta-amyloid measures and magnetic resonance imaging atrophy both predict time-toprogression from mild cognitive impairment to Alzheimer’s disease. Brain 133:3336–3348PubMedCrossRefGoogle Scholar
Mosconi L, Tsui WH, Herholz K et al (2008) Multicenter standardized 18F-FDG PET diagnosis of mild cognitive impairment, Alzheimer’s disease, and other dementias. J Nucl Med 49:390–398PubMedCrossRefGoogle Scholar